KRAS and neoplasm: We assessed the association between tumor molecular variables (CIMP, LINE-1, KRAS, BRAF and PIK3CA) and TGFBR2 mutation and did not find significant relation between TGFBR2 mutation and KRAS or BRAF mutation.